Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Is There Momentum Behind The Dechra Pharmaceutical Share Price?

Published 25/11/2020, 09:12
Updated 09/07/2023, 11:32

It has been a wild ride for some of the UK's biggest quoted companies this year. Economic uncertainty persists and the question on the minds of many investors is where the prices of stocks like Dechra Pharmaceuticals (LON:DPH) will go from here.

Dechra Pharmaceuticals is one of a surprisingly small number of special shares on the London Stock Exchange that have market valuations in excess of £1 billion. The stock currently has a market capitalisation of £3,431m.

These large-cap shares are closely watched because they have an important influence on the investment funds and pension portfolios of millions of savers. So amid the chaos of Covid-19, how has the stock fared?

Over the past 12 months, the Dechra Pharmaceuticals share price has seen an absolute move of 13.4%. On a relative basis - which take into account the movement of the wider market - the shares have moved by 29.5% over the past year and by 6.44% over the past six months.

But what now?

Do analysts rate it as a buy, sell or hold?

Regardless of recent performance, the main question for investors is what the future holds. In uncertain economic conditions, it's often difficult to get an accurate view. The good news is that analysts generally understand the market's biggest businesses better than most, so they are well-placed to make predictions. That shows up in their Buy, Hold and Sell recommendations.

Among the analysts covering Dechra Pharmaceuticals, there are currently:

  • 3 Buy recommendations
  • 5 Hold recommendations
  • 1 Sell recommendations

With this kind of information, it's possible to start forming a view about the outlook for any share. A combination of recent price performance and analyst recommendations gives you a flavour of whether the market is expecting a bright future - or whether there are causes for concern.

It's also worth looking at the profile of the stock to understand whether it has strong positive exposure to important factors like Quality, Value and Momentum. On that basis, Stockopedia currently classifies Dechra Pharmaceuticals as a high flyer. You can read more about what that means here.

What does this mean for potential investors?

Dechra Pharmaceuticals is one of the most closely watched shares in the market. But while price trends and broker recommendations can give you an idea about the sentiment around a stock, they can't tell you everything.

To get a better understanding of the overall investment case, it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Dechra Pharmaceuticals that you can find out about here.

Disclaimer: These articles are provided for information purposes only. The content is not intended to be a personal recommendation. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser. The author has no position in the stocks mentioned, unless otherwise stated.

Original Post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.